Malaysian biosimilar products to be sold in Asean countries


KUALA LUMPUR: Inno Bio Ventures Sdn Bhd and Aryogen Biopharma have sealed a partnership to market and distribute four biosimilar products at affordable prices among Asean countries.

Following a memorandum of understanding inked on Tuesday, the companies have exclusive rights to market the locally-made biosimilar drugs in Vietnam, Philippines, Myanmar, Laos and Cambodia.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Inno bio biosimilar

   

Next In Business News

BNP lays off a dozen China dealmakers amid fee plunge
Oil pares losses on tight supply but cloudy demand caps gains
Thailand's currency, stocks rally on economic, earnings momentum; Asia FX mixed
Global EV sales up 35% in October, Europe ekes out a gain
Trump names Elon Musk to role leading government efficiency drive
Malaysia's new vehicle sales drop 8.3% in October 2024
Measures rolled out to promote growth of inland business hubs
Stocks slide on unease over jump in bond yields as focus turns to US inflation
Dollar, bitcoin slow momentum as markets eye US inflation
MMHE records net profit of RM15.27mil in 3Q

Others Also Read